Teva offers generic TecfideraTeva’s generic is available in dosage strengths of 120 mg and 240 mg, as well as in bottle sizes of 14 capsules and 60 capsules, respectively. FDA clears Cipla’s Tecfidera genericFor the year ended July 2020, IQVIA data showed U.S. sales of roughly $3.8 billion for Tecfidera. Taro launches generic of Ferriprox Dr. Reddy's launches generic Precedex Brand and generic sales for Precedex in 0.9% sodium chloride injection were $210 million for the most recent 12 months ended June 2020, according to IQVIA. Camber intros generic Tecfidera Camber's generic Tecfidera provides a treatment for relapsing forms of multiple sclerosis. Bausch Health, Alfasigma resolve Xifaxan litigation with Sun Pharma Salix will maintain market exclusivity for Xifaxan (rifaximin) 200 mg and 550 mg tablets until 2028. Zydus Cadila obtains FDA green light for generic K-Dur Zydus Cadila’s generic K-Dur will be available in dosage strengths of 750 mg and 1,500 mg. SPARC licenses commercialization rights of Elepsia XR to Tripoint Therapeutics Tripoint will commercialize SPARC's Elepsia XR tablets for five years, with the option to extend the agreement further. FDA letter sets back Hikma's generic Advair Diskus Hikma said it now expects to receive FDA approval for its generic Advair Diskus in early 2021. Lupin intros generic Depakote ER Divalproex sodium ER tablets had a market value of approximately $130 million, according to IQVIA July 2020 data. First Previous 147 148 149 150 151 Next Last
